EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries

Francesco Branda iD, Marta Giovanetti iD, Leonardo Sernicola, Stefania Farcomeni, Massimo Ciccozzi iD, Alessandra Borsetti iD

Pathogens · 2024

DOI: 10.3390/pathogens13020102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Francesco Branda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Rome, Italy. Hauptthemen laut MEDLINE: Drug Resistance, Viral, HIV-1, HIV Infections, HIV Integrase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PON “Ricerca e Innovazione” 2014–2020, CRP-ICGEB RESEARCH GRANT 2020 Project, CRP/BRA20-03, Contract CRP/20/03..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing emergence of non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV drug resistance in sub-Saharan Africa (SSA) led to the World Health Organization (WHO) recommending, in 2018, a transition to dolutegravir (DTG) as a first-line antiretroviral therapy (ART) in SSA. The broad HIV-1 genetic diversity in SSA could shape DTG effectiveness and the pattern of drug resistance mutations (DRMs) in this region. This study evaluated HIV-1 integrase (IN) DRMs and conserved regions among published groups M, N, O, and P HIV-1 sequences spanning forty years of the HIV epidemic during the transition of DTG-based ART. Overall, we found low levels of integrase strand transfer inhibitor (INSTI)-DRMs (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, ViralHIV-1HIV InfectionsHIV IntegraseMutationHIV Integrase InhibitorsHumansOxazinesPyridonesHeterocyclic Compounds, 3-RingAfrica South of the SaharaPiperazinesDolutegravir

Stichwörter der Autor:innen

African countriesHIV-1drug resistanceintegraseviral evolution

Substanzen

HIV IntegraseHIV Integrase InhibitorsOxazinesPyridonesHeterocyclic Compounds, 3-RingPiperazinesDolutegravirp31 integrase protein, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
  • Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
  • Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil.
  • Climate Amplified Diseases and Epidemics (CLIMADE), Brasilia 70070-130, Brazil.
  • National HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, 00161 Rome, Italy.

ORCID-Profile: Francesco Branda, Marta Giovanetti, Massimo Ciccozzi, Alessandra Borsetti

Förderung

  • PON “Ricerca e Innovazione” 2014–2020
  • CRP-ICGEB RESEARCH GRANT 2020 Project
  • CRP/BRA20-03, Contract CRP/20/03.
  • CRP-ICGEB RESEARCH GRANT 2020 Project CRP/BRA20-03

Zitieren

APA

Branda, F., Giovanetti, M., Sernicola, L., Farcomeni, S., Ciccozzi, M., & Borsetti, A. (2024). Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries. Pathogens. https://doi.org/10.3390/pathogens13020102

Vancouver

Branda F, Giovanetti M, Sernicola L, Farcomeni S, Ciccozzi M, Borsetti A. Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries. Pathogens. 2024. doi:10.3390/pathogens13020102

BibTeX
@article{Branda2024,
  author = {Branda, Francesco and Giovanetti, Marta and Sernicola, Leonardo and Farcomeni, Stefania and Ciccozzi, Massimo and Borsetti, Alessandra},
  title = {Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13020102}
}
Kostenlos starten →